Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Sandoz reports new NMDA antagonist

July 5, 1996

Cephalon reveals multicatalytic protease inhibitors

July 5, 1996

NMDA antagonists reported by Zeneca

July 5, 1996

Novo Nordisk claims mGluR antagonists for CNS disorders

July 5, 1996

Servier's prolyl endopeptidase inhibitor effective in amnesia model

July 5, 1996

Anseculin HCl enters phase II clinical trials

July 5, 1996

Toyama discloses NGF-promoting agents

July 5, 1996

Dolasetron equiefficent to granisetron in chemotherapy-induced emesis

July 5, 1996

Regeneron, Medtronic to collaborate on Axokine delivery system

July 5, 1996

Sumitomo claims psychotropic lactam derivatives

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.